How Clinton's 'Trump Is Crazy’ Strategy Could

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
How Clinton's 'Trump Is Crazy’ Strategy Could Backfire
LBJ used the same “frontlash” strategy in 1964. He won in the short term. But in the long run, it proved an illusory triumph.
September 03, 2016

Hillary Clinton wants America to think that Trump is unfit to be president. Her ads portray him as erratic and unsteady. In interviews, she calls him “unqualified” and a “threat" to democracy.

“This is not someone who should ever have the nuclear codes,” Clinton said in a speech back in June. It’s a line of attack that could well help Clinton broaden her base. Last month, the Clinton presidential campaign launched an initiative to court moderate Republicans and independents who would ordinarily balk at supporting a Democratic nominee, but whose loathing for Donald Trump might persuade them to pull the lever for the former secretary of state. That was just after a new Clinton campaign ad featured prominent conservatives questioning Trump’s fitness to be commander-in-chief.

The strategy is simple: Go after the middle, flaunt your high-profile GOP supporters and paint Trump as a lunatic. In other words, make the election a referendum on The Donald’s fitness to serve as the world’s most powerful head of state.

There’s precedent for this approach. In 1964, Lyndon Johnson’s reelection campaign aggressively pursued a strategy known as “frontlash” in which it positioned GOP nominee Barry Goldwater as a singularly dangerous extremist and made a strong play for independent and Republican voters. “Our main strength lies not so much in the for Johnson but in the against Goldwater,” presidential adviser Jack Valenti candidly informed LBJ. “We must make him ridiculous and a little scary: trigger-happy, a bomb thrower, a radical … not the nation’s leader, [he] will sell TVA, cancel Social Security, abolish the government, stir trouble in NATO, be the herald of WWIII.” Bill Moyers, the president’s closest aide, was in full agreement. The central message of the president’s campaign would be that Goldwater “could do these things,” he advised “—but only if we let him.”

Frontlash proved a winning strategy in the short run: Johnson defeated Goldwater in a landslide. But in the longer term, it proved an illusory triumph. By uniting moderates against Goldwater, the president’s campaign failed to build a strong coalition for Great Society liberalism. And as Hillary Clinton’s campaign mounts a similar strategy, the story of what frontlash accomplished, and what it didn’t, should serve as a warning.

In Barry Goldwater, LBJ found the perfect opponent. Presidential journalist Teddy White observed that his “candor is the completely unrestrained candor of old men and little children.” The Arizona senator proposed authorizing NATO commanders to deploy atomic weapons. (“Let’s lob one into the men’s room of the Kremlin,” he offered on one occasion.) He suggested that the Tennessee Valley Authority—a landmark New Deal program that brought electricity to much of the rural and impoverished South—be privatized and Social Security made a voluntary program. He dismissed the Republican Eisenhower administration as a “dime-store New Deal,” and offered that “this country would be better off if we could just saw off the Eastern Seaboard and let it float out to sea.” Given his extreme temperament, it was unsurprising that his movement attracted the enthusiastic support of far-right fringe groups like the John Birch Society. “We’ve got superpatriots running through the woods like a collection of firebugs,” complained one of his state organizers, “and I keep running after them, like Smokey the Bear, putting out fires. We just don’t need any more enemies.”

LBJ bore his opponent no personal ill will. Goldwater was an affable bon vivant—liberal in his consumption of liquor, a convivial member of the Senate club and easy to like. But the president regarded Goldwater’s ideology as well outside the mainstream. In a private conversation with Texas Governor John Connally, Johnson candidly sized up his opponent as “just nutty as a fruitcake.” And that was the crux of the matter. As presidential adviser Horace Busby observed, “the attack should be broadened on the extremes and factions. Republicans should be told, in effect, that their party is being taken over not by Birchites and Klansmen, but by the Reverend Billy Hargis”—an archconservative, segregationist preacher who pledged his support to Goldwater—“and all the other Right Wing Kooks who can be fairly named … these are real and valid issues.”

Early on in 1964, the pollster Oliver Quayle coined a term to describe this strategy: frontlash. It was the opposite of white backlash against liberalism. By presenting themselves as the “party of stability and responsibility and calm judgement,” a reporter observed, Democrats would “make it easier for moderate-minded Republicans to vote for President Johnson.”

Under the careful direction of Moyers and Valenti, the upstart advertising firm Doyle Dane Bernbach (DDB) produced a series of scathing 30-second and 60-second spots that ran at regular intervals—the first time in a presidential campaign cycle that networks broke with the tradition of selling 5-minute and 15-minute time slots at the end of a program.

In one DDB ad, the camera lingered over a telephone with a flashing red light. “This particular phone only rings in a serious crisis,” a narrator explained in a grave tone. “Leave it in the hands of a man who has proven himself responsible.” Another depicted a young girl licking an ice cream as a female narrator asked, “Know what people used to do? They used to explode bombs in the air. You know, children should have lots of vitamin A and calcium. But they shouldn’t have strontium 90 or cesium 137.” The narrator explained that reasonable leaders came together several years earlier to sign a Nuclear Test Ban Treaty, thus ridding the atmosphere of harmful nuclear radiation. “Now there’s a man who wants to be president of the United States,” she continued. “His name is Barry Goldwater. If he’s elected, they might start testing all over again.” In the background, a Geiger counter ticked away.



Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 194

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Container Store Group Faces Delisting by NYSE Amid Market Challenges

Updated Category News Views 145

Container Store Group's NYSE Delisting Announcement The New York Stock Exchange (NYSE) has made a significant announcement regarding the trading status of The Container Store Group, Inc. (TCS). The Exchange's staff has determined that it will initiate proceedings to delist the Company's common stock. This decision comes in light of the Company's recent performance in the...

Continue Reading
Investing in Vanguard Russell 2000 ETF: A Strategic Approach

Updated Category News Views 200

Investing in the Vanguard Russell 2000 ETF: A Strategic Approach In recent years, the stock market's performance has been largely driven by large corporations. While megacap tech stocks have thrived, small-cap stocks have struggled to keep pace. This has resulted in significant valuation discounts for smaller companies compared to their larger peers. Over the past five...

Continue Reading
Welcoming Ann Dunkin to Our Esteemed Board of Directors

Updated Category News Views 156

Ann Dunkin Joins Our Board of Directors We are thrilled to announce the appointment of Ann Dunkin, P.E., to our Board of Directors. With an extensive background in engineering and a strong commitment to public service, Ann's diverse expertise will be invaluable as we navigate the challenges and opportunities in our industry. Professional Background of Ann Dunkin Ann...

Continue Reading
Management Trading Insights on Unexpected Developments

Updated Category News Views 150

Understanding Management Trading Activities When assessing a company's health and future prospects, observing management trading can provide invaluable insights. Executive transactions—buying or selling shares—often reflect their confidence in the business's performance. An increase in stock purchases by management usually signals optimism, while significant sales may...

Continue Reading
Tovecimig's Efficacy in Biliary Tract Cancer Study Unveiled

Updated Category News Views 254

Breakthrough Findings in Biliary Tract Cancer Treatment Compass Therapeutics, Inc. has announced promising interim results from their ongoing Phase 2/3 study, COMPANION-002, examining the efficacy of tovecimig, formerly known as CTX-009, in combination with paclitaxel for treating advanced biliary tract cancer (BTC). Tovecimig, a bispecific antibody targeting both DLL4...

Continue Reading